https://www.ajmc.com/view/nirmatrelvir-ritonavir-reduces-risk-of-covid-19-hospitalization-death-study-finds
0
0
The body of research on nirmatrelvir-ritonavir demonstrates a plethora of benefits in the treatment of COVID-19, and authors of a recent study identified more advantages to administering the treatment to patients with COVID-19.
Create an account
or login to join the discussion